Browse our library of editorials by BPH experts for practical insights into the treatment of benign prostatic hyperplasia.
DEC 2022
Rezūm™ Water Vapor Therapy vs. medication for BPH/LUTS patients
Editorial Commentary:
Kevin T. McVary, MD, FACS
Kevin T. McVary, MD, FACS
GreenLight™ and TURP: An Evolving Gold Standard in BPH Treatment
Lewis S. Kriteman, MD, FACS
Putting Post-Procedure Catheterization into Perspective
Christopher Cantrill, MD
Bilal Chughtai, MD
Amy Pearlman, MD
GreenLight™ After UroLift™: Practice Insights From Physicians
David Robbins, MD
Ricardo Gonzalez, MD
Rahul Mehan, MD
Physician Roundtable: Experiences with minimally invasive treatments for BPH
Dean Elterman, MD, MSc, FRCSC
James E. Fagelson, MD, FACS
Shammai Rockove, MD, FACS
Justin Cohen, MD
Anthony Golio, MD, FACS
Final Five-Year Results from the Rezūm™ Water Vapor Therapy Pivotal Clinical Trial: A Closer Look at the Data
Kevin T. McVary, MD, FACS
Rezūm Therapy Procedural Approaches
Christopher H. Cantrill, MD
Kevin C. Zorn, MD
Dean S. Elterman, MD
Ricardo R. Gonzalez, MD
The Science of Steam: Treating BPH Safely, Efficiently and Effectively
Neal D. Shore, MD, FACS
Top Considerations for Minimally Invasive Treatment for Benign Prostatic Hyperplasia
Bilal Chughtai, MD
Dean Elterman, MD
Rezūm™ Water Vapor Therapy for BPH: A Physician’s Perspective as a Surgeon and Patient
J. Randolf Beahrs, MD
